background
viral
pathogen
gener
regard
import
caus
sever
hospitalacquir
pneumonia
hap
except
patient
hematolog
malign
transplant
recipi
investig
role
distribut
virus
adult
sever
hap
requir
intens
care
method
march
februari
adult
patient
sever
hap
requir
admiss
intens
care
unit
icu
medic
icu
tertiari
care
hospit
prospect
enrol
respiratori
virus
detect
use
multiplex
reversetranscript
polymeras
chain
reaction
andor
shell
vial
cultur
result
total
patient
enrol
patient
underw
bronchoscop
bal
etiolog
diagnosi
one
hundr
fiftysix
patient
bacteri
infect
patient
viral
infect
virus
detect
bal
fluid
specimen
patient
commonli
identifi
virus
respiratori
syncyti
viru
parainfluenza
viru
follow
rhinoviru
influenza
viru
twentyon
patient
bacterialvir
coinfect
staphylococcu
aureu
commonli
coexist
bacteria
n
viral
infect
nonimmunocompromis
patient
uncommon
although
frequent
immunocompromis
patient
nonimmunocompromis
patient
significantli
older
immunocompromis
patient
significantli
higher
rate
underli
chronic
obstruct
pulmonari
diseas
tubercul
destroy
lung
chronic
kidney
diseas
day
mortal
patient
bacteri
infect
viral
infect
bacterialvir
coinfect
significantli
differ
respect
p
conclus
viral
pathogen
uncommon
adult
patient
sever
hap
requir
icu
admiss
sinc
viral
pathogen
may
caus
sever
hap
could
potenti
sourc
viral
transmiss
investig
requir
delin
role
viral
pathogen
sever
hap
hospitalacquir
pneumonia
hap
second
common
nosocomi
infect
sever
hap
requir
treatment
intens
care
unit
icu
associ
high
morbid
mortal
bacteri
pathogen
well
known
princip
caus
hap
speci
includ
staphylococcu
aureu
includ
methicillinresist
aureu
mrsa
pseudomona
aeruginosa
acinetobact
speci
klebsiella
pneumonia
escherichia
coli
tradit
respiratori
virus
given
minim
attent
caus
hospitalacquir
infect
although
sever
previou
investig
report
role
respiratori
virus
studi
mainli
confin
patient
hematolog
malign
hematopoiet
stem
cell
solid
organ
transplant
recipi
also
studi
includ
upper
respiratori
tract
infect
lower
respiratori
tract
infect
distinguish
hospitalacquir
communityacquir
infect
hospitalacquir
respiratori
viral
infect
includ
influenza
viru
human
respiratori
syncyti
viru
human
metapneumoviru
sarscoronaviru
outbreak
demonstr
previous
nonimmunocompromis
patient
well
immunocompromis
patient
recent
year
use
molecular
diagnost
method
especi
polymeras
chain
reaction
pcr
assay
improv
abil
detect
respiratori
virus
clinic
specimen
includ
newli
discov
respiratori
virus
human
metapneumoviru
human
coronavirus
bocaviru
sever
previou
investig
compar
pcr
convent
method
viral
cultur
antigen
detect
serolog
assay
viru
identif
show
incid
viral
infect
consider
underestim
absenc
pcr
use
multiplex
reversetranscript
pcr
method
previous
show
viral
infect
common
bacteri
infect
adult
patient
commun
sever
pneumonia
requir
icu
admiss
exclud
influenza
infect
best
knowledg
investig
focus
role
respiratori
virus
caus
hap
greater
understand
distribut
role
viral
infect
might
provid
new
insight
hap
object
current
studi
investig
incid
distribut
virus
adult
patient
sever
hap
requir
icu
admiss
need
inform
consent
waiv
view
observ
natur
studi
intervent
perform
protocol
standard
clinic
form
includ
waiver
inform
consent
approv
asan
medic
center
institut
review
board
irb
number
studi
perform
medic
icu
asan
medic
center
tertiari
referr
hospit
seoul
republ
korea
universityaffili
teach
hospit
bed
eight
icu
studi
period
adult
patient
sever
hap
requir
icu
care
refer
medic
icu
medic
icu
close
unit
manag
five
boardcertifi
intensivist
intensivist
attend
structur
twice
daili
bedsid
round
fiberopt
bronchoscopi
bronchoalveolar
lavag
bal
prefer
perform
patient
bilater
interstiti
pattern
infiltr
nonresolv
pneumonia
discret
physician
judgment
bal
protocol
describ
detail
elsewher
prospect
cohort
studi
conduct
year
period
march
februari
consecut
adult
patient
sever
hap
includ
studi
investig
prospect
collect
data
patient
demographi
comorbid
smoke
habit
laboratori
data
includ
microbiolog
test
radiolog
find
clinic
featur
length
icu
hospit
stay
outcom
diseas
sever
evalu
acut
physiolog
chronic
health
evalu
apach
ii
sequenti
organ
failur
assess
sofa
score
underli
diseas
classifi
accord
mccabe
jackson
classif
sinc
includ
patient
sever
hap
present
studi
cohort
none
current
patient
overlap
prior
studi
analyz
patient
sever
cap
hcap
hap
defin
accord
american
thorac
societi
infecti
diseas
societi
america
guidelin
includ
presenc
new
persist
radiograph
infiltr
occur
hour
admiss
plu
two
follow
fever
higher
hypothermia
ii
leukocytosi
white
blood
cell
iii
purul
tracheal
aspir
sputum
pneumonia
classifi
sever
patient
requir
mechan
ventil
state
septic
shock
need
vasopressor
icu
admiss
patient
classifi
immunocompromis
administ
corticosteroid
daili
least
mg
per
day
prednisolon
equival
drug
ii
seroposit
human
immunodefici
viru
iii
receiv
solid
organ
hematopoiet
stem
cell
transplant
iv
receiv
treatment
radiat
therapi
chemotherapi
underli
malign
month
prior
hospit
admiss
v
underli
acquir
immun
defici
disord
microbiolog
evalu
conduct
accord
standard
procedur
previous
describ
includ
three
set
blood
cultur
gram
stain
cultur
sputum
endotrach
aspir
bal
fluid
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophila
binax
inc
portland
main
usa
pcr
use
detect
atyp
bacteri
pathogen
l
pneumophila
mycoplasma
pneumonia
chlamydophila
pneumonia
use
bd
probetec
et
atyp
pneumonia
assay
becton
dickinson
spark
usa
microorgan
identifi
specimen
collect
within
hour
diagnosi
pneumonia
includ
pathogen
respiratori
virus
test
multiplex
reversetranscript
pcr
rtpcr
assay
use
seeplex
ace
detect
kit
seegen
inc
seoul
korea
influenza
b
virus
adenoviru
parainfluenza
viru
type
respiratori
syncyti
viru
type
b
rhinoviru
human
metapneumoviru
enteroviru
human
coronavirus
bocaviru
shell
vial
cultur
perform
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
cytomegaloviru
adenoviru
diagnost
hybrid
inc
athen
usa
use
bal
sampl
data
analys
use
ibm
spss
window
version
ibm
corp
armonk
ny
usa
result
express
mean
sd
median
interquartil
rang
iqr
either
chisquar
test
fisher
exact
test
use
compar
categor
variabl
student
test
mannwhitney
u
test
use
compar
continu
variabl
variabl
present
p
valu
less
univari
analysi
includ
multipl
logist
regress
model
result
express
adjust
odd
ratio
aor
confid
interv
ci
p
valu
less
consid
statist
signific
studi
period
total
patient
admit
medic
icu
patient
diagnos
pneumonia
hap
communityacquir
pneumonia
cap
healthcareassoci
pneumonia
hcap
exclud
hap
patient
meet
criteria
sever
pneumonia
total
patient
sever
hap
final
includ
analysi
baselin
clinic
characterist
underli
diseas
list
tabl
mean
age
year
median
length
hospit
stay
prior
pneumonia
diagnosi
day
iqr
main
underli
diseas
hematolog
malign
n
diabet
mellitu
n
structur
lung
diseas
n
solid
cancer
n
patient
categor
immunocompromis
state
recent
receiv
chemotherapi
andor
radiat
therapi
receiv
corticosteroid
therapi
administ
nonsteroid
immunosuppress
receiv
bone
marrow
transplant
receiv
solid
organ
transplant
tabl
mean
apach
ii
mean
sofa
score
total
patient
underw
mechan
ventil
patient
clinic
present
septic
shock
time
icu
admiss
one
respiratori
pathogen
determin
patient
patient
underw
bronchoscop
bal
etiolog
diagnosi
figur
distribut
respiratori
pathogen
shown
tabl
bacteri
infect
observ
patient
diagnos
sole
bacteri
infect
viral
infect
found
patient
diagnos
sole
viral
infect
coinfect
patient
includ
bacterialvir
coinfect
seven
viralfung
coinfect
viral
infect
found
immunocompromis
patient
nonimmunocompromis
patient
identif
viral
pathogen
accord
immunocompromis
condit
summar
tabl
overal
viral
pathogen
identifi
patient
patient
infect
one
type
viru
two
differ
pathogen
detect
eight
patient
three
pathogen
detect
two
patient
distribut
viral
pathogen
specimen
test
posit
shown
tabl
tabl
distribut
viral
pathogen
patient
without
coinfect
shown
tabl
patient
viral
infect
coinfect
organ
includ
bacteria
anoth
viru
seven
fungu
commonli
coexist
bacteria
aureu
n
baumannii
n
clinic
characterist
outcom
patient
without
coinfect
significantli
differ
tabl
tabl
summar
combin
pathogen
found
bacterialvir
coinfect
common
combin
found
respiratori
syncyti
viru
aureu
n
follow
respiratori
syncyti
viru
b
aureu
baumannii
n
characterist
patient
viral
infect
summar
tabl
nonimmunocompromis
patient
significantli
like
older
immunocompromis
patient
commonli
underli
chronic
obstruct
pulmonari
diseas
copd
tubercul
destroy
lung
chronic
kidney
diseas
although
mean
apach
ii
score
upon
icu
admiss
tend
higher
nonimmunocompromis
patient
immunocompromis
host
vs
nonimmunocompromis
host
p
clinic
manifest
similar
two
group
figur
show
season
respiratori
viru
infect
studi
period
respiratori
syncyti
viru
commonli
found
april
august
parainfluenza
viru
predomin
juli
decemb
rhinoviru
present
throughout
year
common
spring
winter
influenza
viru
mainli
present
winter
human
coronaviru
present
februari
march
result
analysi
risk
factor
associ
day
mortal
given
tabl
overal
day
mortal
rate
studi
popul
inhospit
mortal
rate
median
icu
stay
day
iqr
day
mortal
rate
bacteri
infect
sole
bacteri
infect
viral
infect
sole
viral
infect
bacterialvir
coinfect
multipl
logist
regress
analysi
independ
predictor
day
mortal
associ
presenc
shock
aor
ci
p
immunocompromis
state
aor
ci
main
find
present
studi
viral
infect
uncommon
critic
ill
adult
patient
sever
hap
virus
identifi
sever
hap
patient
immunocompromis
nonimmunocompromis
nonimmunocompromis
patient
older
immunocompromis
patient
commonli
copd
tubercul
destroy
lung
diseas
chronic
kidney
diseas
viral
infect
associ
compar
mortal
rate
bacteri
infect
knowledg
first
studi
focus
respiratori
viral
pathogen
adult
patient
sever
hap
strength
studi
virus
detect
bal
fluid
specimen
nearli
twothird
subject
patient
suggest
consider
number
identifi
virus
regard
actual
pathogen
result
respiratori
syncyti
viru
parainfluenza
viru
rhinoviru
common
viral
pathogen
observ
patient
viral
infect
prior
studi
regard
patient
hematolog
malign
hematopoiet
stem
cell
transplant
solid
organ
transplant
also
show
respiratori
syncyti
viru
influenza
viru
parainfluenza
viru
major
viral
pathogen
popul
rhinoviru
wellknown
caus
common
cold
increasingli
recogn
import
caus
lower
respiratori
tract
infect
mainli
sever
immunocompromis
patient
hematopoiet
stem
cell
transplant
patient
current
studi
cohort
rhinoviru
found
third
commonli
identifi
pathogen
commonli
associ
sever
hap
compar
influenza
viru
howev
signific
rhinoviru
detect
respiratori
specimen
pneumonia
patient
subject
debat
earlier
studi
indic
chronic
shed
rhinovirus
week
uncommon
immunocompet
individu
immunocompromis
patient
present
studi
rhinovirus
identifi
bal
fluid
rhinovirusposit
case
suggest
least
case
virus
would
signific
pathogen
rather
colon
present
studi
compar
previou
result
regard
cap
hcap
proport
human
metapneumoviru
found
much
lower
sever
hap
case
cap
hcap
chronic
kidney
diseas
tabl
taken
togeth
data
suggest
even
patient
known
immunocompromis
viral
infect
consid
patient
elderli
especi
structur
lung
diseas
chronic
kidney
diseas
impact
coinfect
respiratori
virus
organ
import
issu
prior
studi
viral
pneumonia
patient
hematolog
malign
receiv
haematopoiet
stem
cell
transplant
report
lower
incid
coinfect
rang
present
analys
found
previous
adult
cap
tabl
demograph
clinic
characterist
ident
pathogen
outcom
patient
sever
pneumonia
b
categori
coinfect
mutual
exclus
case
associ
two
pathogen
b
case
coinfect
organ
bacteriaoth
viru
six
aspergillu
speci
four
p
jirovecii
present
tabl
c
immunocompromis
state
verifi
patient
daili
administr
corticosteroid
least
mg
per
day
prednisolon
equival
drug
ii
solid
organ
hematopoiet
stem
cell
transplant
recipi
iii
receiv
treatment
chemotherapi
underli
malign
month
prior
icu
admiss
iv
underli
acquir
immun
defici
disord
includ
two
patient
chronic
renal
failur
two
patient
endstag
renal
diseas
coinfect
commonli
identifi
patient
identifi
viral
pathogen
infect
singl
viru
coinfect
bacteria
coinfect
anoth
viru
cap
report
shown
polymicrobi
infect
associ
poorer
outcom
coinfect
influenza
plu
pneumococc
infect
result
howev
clinic
manifest
outcom
patient
without
coinfect
significantli
differ
tabl
none
combin
polymicrobi
pathogen
dominantli
observ
day
mortal
patient
bacteri
infect
viral
infect
bacterialvir
coinfect
p
respect
howev
consid
rel
small
number
patient
variou
combin
pathogen
sever
underli
diseas
comorbid
investig
requir
larger
popul
season
distribut
respiratori
viral
infect
hap
similar
infect
cap
respiratori
syncyti
viru
influenza
viru
frequent
winter
spring
parainfluenza
viru
mainli
present
summer
autumn
rhinoviru
found
throughout
year
indic
hospitalacquir
viral
infect
occur
coincid
spread
viral
infect
commun
therefor
watch
monitor
communitylevel
viral
infect
studi
sever
limit
first
studi
conduct
singl
center
includ
patient
sever
pneumonia
admit
medic
icu
thu
result
may
generaliz
second
sinc
studi
observ
one
could
interven
term
specif
procedur
laboratori
test
therefor
patient
undergo
bronchoscop
bal
test
respiratori
viru
mean
actual
rate
viral
infect
might
higher
indic
result
third
among
patient
viral
infect
virus
isol
sole
nasopharyng
specimen
patient
case
might
includ
case
coincident
upper
respiratori
viral
infect
final
perform
viru
test
herp
simplex
viru
known
caus
pneumonia
especi
immunocompromis
patient
hematolog
malign
conclus
viral
pathogen
uncommonli
identifi
adult
patient
sever
hap
requir
intens
care
virus
could
respons
sever
hap
could
repres
potenti
sourc
intraor
interhospit
transmiss
investig
requir
delin
preval
role
viral
pathogen
sever
hap
precis
tabl
identif
viral
pathogen
accord
immunocompromis
condit
patient
two
immunocompromis
condit
b
case
associ
two
virus
c
daili
administr
corticosteroid
least
mg
per
day
prednisolon
equival
drug
doc
ident
viral
pathogen
patient
without
coinfect
categori
coinfect
mutual
exclus
case
associ
two
pathogen
b
case
coinfect
organ
bacteriaoth
virus
six
aspergillu
speci
four
p
jirovecii
present
tabl
c
coexist
bacteria
aureu
n
baumannii
n
maltophilia
n
p
aeruginosa
n
e
coli
n
k
pneumonia
n
pneumonia
n
doc
